Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9

Miho Terao, Moe Tamano, Satoshi Hara, Tomoko Kato, M. Kinoshita, S. Takada
{"title":"Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9","authors":"Miho Terao, Moe Tamano, Satoshi Hara, Tomoko Kato, M. Kinoshita, S. Takada","doi":"10.1538/expanim.15-0116","DOIUrl":null,"url":null,"abstract":"The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice.","PeriodicalId":75961,"journal":{"name":"Jikken dobutsu. Experimental animals","volume":"65 1","pages":"275 - 283"},"PeriodicalIF":0.0000,"publicationDate":"2016-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1538/expanim.15-0116","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jikken dobutsu. Experimental animals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1538/expanim.15-0116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice.
利用CRISPR/Cas9系统利用crRNA/tracrRNA与Cas9 nickase和FokI-dCas9高效生产突变小鼠
CRISPR/Cas9系统是生产转基因动物的强大基因组编辑工具。为了产生突变小鼠,将嵌合单导RNA (chimeric single-guide RNA, sgRNA)克隆到质粒载体中,并将sgRNA和Cas9的混合物微量注射到受精卵中。与使用CRISPR/Cas9系统进行基因操作相关的一个问题是,可能存在脱靶效应。为了简化CRISPR/Cas9系统引起的低脱靶风险的突变小鼠的生产,我们证明了通过将化学合成的CRISPR RNA (crRNA)、反式激活的crRNA (tracrRNA)和修饰的Cas9(如nickase版本和foki融合催化失活的Cas9)微量注射到受精卵中,可以有效地获得转基因小鼠。使用这种方法,不再需要将sgRNA克隆到质粒载体中,这使得突变小鼠的高通量生产成为可能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信